CG-842

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCG-842
Drug Alias NameClaragen-Oralrecombinant human uteroglobin (Clarassance)recombinant human CC10 (Clarassance)CG-842
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionSecretoglobin family 1A member 1 stimulants
TargetsSecretoglobin family 1A member 1
Therapy Area/IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTherabron Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherabron Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A